SAMSUNG PHARMACEUTICAL.CO (001360)

KOSPI · 1,299 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

122.3B

PBR

1.01

52W

1K~2K

SAMSUNG PHARMACEUTICAL.CO operates in the Pharmaceuticals sector.

Legal name: SAMSUNG PHARMACEUTICAL.CO.,Ltd.

As of the Aug 26, 2026 close, the market capitalization was 122.3 billion KRW, with a P/B of 1.01.

These figures can be verified in the DART filing (receipt no. 20260318001547).

2 applicable out of 8 items

Large Shareholding Report (Simplified)

Semi-Annual Report (2026.06)

Material Event Report (Early CB Retirement Decision)

Checks

2 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: No administrative designation criteria met.

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.2% potential dilution.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: 1 embezzlement/litigation filing(s) in the last 180 days. [source]

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: No market actions recorded in the last 180 days.

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-25	Large Shareholding Report (Simplified)
2026-08-14	Semi-Annual Report (2026.06)
2026-08-12	Material Event Report (Early CB Retirement Decision)